Catalyst Wire Dossier Catalyst Wire Dossier

Romosozumab (Evenity)

romosozumab · Amgen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Romosozumab (Evenity), covering 2025-12-19 to 2025-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients [Phase 4]

See pricing